ME Therapeutics Holdings Inc., a preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno‐oncology. Its lead candidate is a novel antibody drug that targets a key protein involved in the generation of suppress...

Sector

Industry

CEO

Dhanji, Salim

Employees

Website

metherapeutics.com

IPO Date

Headquarters

177 Robson Street, Vancouver, British Columbia, V6B 0N3, Canada

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

ME Therapeutics Holdings METX

ME Therapeutics Holdings Earnings Call Summary

ME Therapeutics Holdings Earnings

Transcripts

Events

About ME Therapeutics Holdings Inc.

ME Therapeutics Holdings
METX